Concerns over Novo Nordisk’s growth path is leading Bank of America to step to the sidelines. The bank downgraded the Danish pharmaceutical giant to neutral from buy and decreased its price target to $60. That updated target still implies more than 11% upside from Tuesday’s close. “We have a Neutral rating on Novo Nordisk given…
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. Stocks were slightly lower Tuesday morning, giving up some of the modest gains seen earlier in the session. Even when the S & P 500 was in the green,…
My top 10 things to watch Tuesday, July 29 1. Novo Nordisk shares sank more than 20% this morning after the maker of Ozempic cut its full-year guidance and named a new CEO. The company cited “persistent use of compounded GLP-1s.” Club name Eli Lilly , which competes with Mounjaro and Zepbound, saw its stock…
My top 10 things to watch Wednesday, July 16 1. Wall Street was pacing for a higher open this morning. Wholesale inflation came in cooler than expected, with the June producer price index showing no change from the prior month. That’s in contrast to yesterday’s consumer price index, which picked up month over month. 2….
Here are five key things investors need to know to start the trading day: 1. Market reaction Stocks closed higher Monday as investors hoped that the conflict between the U.S. and Iran would be contained. The Dow Jones Industrial Average climbed 374.96 points, or 0.89%, while the S&P 500 added 0.96% and the Nasdaq Composite rose 0.94%. “Geopolitical risks are undoubtedly…
The “Wegovy” brand slimming syringe is sold in the Achat pharmacy in Mitte. The “Wegovy” slimming syringe has been available in Germany for a year. Jens Kalaene | Picture Alliance | Getty Images Novo Nordisk on Monday said it is ending its collaboration with Hims & Hers due to concerns about the telehealth company’s sales…
After a muted few days for the market, investors in the week ahead will grapple with the fallout of the United States’ decision to enter Israel’s war with Iran. Here’s a closer look at the five big things we’re watching in the market in the week ahead. 1. Geopolitics: President Donald Trump said Saturday night…